معرفی
James C. Robinson is a Professor of Health Economics and the Leonard D. Schaeffer Endowed Chair in Health Economics and Policy at UC Berkeley’s School of Public Health. He chairs the Berkeley Center for Health Technology, focusing on innovative medical technologies’ coverage, management, and payment methods. His expertise spans biotechnology policy, medical device economics, and healthcare payment systems.
Education: PhD in Economics (UC Berkeley), MPH in Health Planning & Policy (UC Berkeley), BA in Economics and Philosophy (UC Santa Cruz). He teaches courses including PH 222A (Health Care Technology Policy) and PH 24 (Economics of Pharmaceutical Innovation).
Research focuses on biosimilars, drug pricing, and payment reforms. His 2024 studies revealed significant hospital markups on cancer drugs, prompting policy discussions on cost savings through biosimilar adoption. Recent grants include a $340,000 Arnold Ventures Foundation award to analyze biosimilar cost impacts.
Labs/Teams: Leads the Berkeley Center for Health Technology, collaborating on projects like the BlueCross BlueShield Axis claims analysis to track biosimilar adoption and pricing trends. His work bridges academic research and policy implementation, emphasizing equitable healthcare access through economic and technological innovation.
